Linked from

The 63 pages that link to Osteoporosis, each with the reason it gives.

• Vertebral columnRelated: Fragile vertebrae can undergo compression fractures and lose height.

• Bone remodelingRelated: Imbalanced remodeling can remove bone faster than it is replaced.

• CorticosteroidRelated: Prolonged systemic corticosteroid use can accelerate bone loss and fracture risk.

• EstrogenRelated: Estrogen loss accelerates bone resorption and contributes to postmenopausal bone loss.

• Bone marrowRelated: Fat and blood-forming marrow interact with bone remodeling and change with age.

• Physical activityRelated: Weight-bearing and resistance activity can support bone health.

• MenopauseRelated: Estrogen loss accelerates bone loss, making fracture prevention relevant after menopause.

• Eating disorderRelated: Low energy availability and hormonal changes can reduce bone density.

• OsteoclastRelated: Excess resorption by osteoclasts can contribute to the loss of bone mass.

• Inflammatory bowel diseaseRelated: Inflammation, low nutrition, and corticosteroid exposure can contribute to bone loss in IBD.

• Hormone replacement therapyRelated: Estrogen therapy can reduce bone loss, though it is not the preferred treatment for every person at fracture risk.

• DexamethasoneRelated: Long-term glucocorticoid exposure, including dexamethasone, accelerates bone loss.

• EstradiolRelated: Estradiol helps preserve bone; low levels can accelerate bone loss.

• Human developmentRelated: Peak bone mass built during development affects vulnerability to this later-life condition.

• Bone mineral densityRelated: Low bone mineral density is a central diagnostic indicator, though not the only determinant of fracture risk.

• HyperthyroidismRelated: Prolonged untreated hyperthyroidism can accelerate bone loss.

• Crohn's diseaseRelated: Inflammation, nutritional deficits, and some treatments can harm bone health in Crohn's disease.

• Anorexia nervosaRelated: Low energy availability and hormonal changes can impair bone formation and density.

• Bone fractureRelated: It can make ordinary forces sufficient to break bone.

• Bone histologyRelated: Histological features can reveal altered bone formation and resorption.

• Klinefelter syndromeRelated: Low testosterone can contribute to reduced bone density, making bone health relevant in care.

• EndocrinologyRelated: Endocrinologists assess hormonal and metabolic causes of bone loss.

• Granulomatosis with polyangiitisRelated: Prolonged glucocorticoid exposure raises bone-loss risk during treatment.

• LevothyroxineRelated: Long-term excessive thyroid hormone exposure can accelerate bone loss.

• OsteologyRelated: Its structural effects are assessed through clinical osteology and density measurement.

• AmenorrheaRelated: Long-lasting estrogen deficiency can weaken bones and raise osteoporosis risk.

• Graves diseaseRelated: Prolonged untreated hyperthyroidism can accelerate bone loss.

• HypopituitarismRelated: Long-standing sex hormone or growth hormone deficiency can weaken bone.

• Polymyalgia rheumaticaRelated: It is a major potential consequence of extended glucocorticoid exposure during treatment.

• Primary biliary cholangitisRelated: Chronic cholestatic liver disease is associated with bone loss and fracture risk.

• Calcium gluconateRelated: Calcium supports bone mineralization, but calcium gluconate alone does not treat osteoporosis.

• HomocystinuriaRelated: Low bone density and fractures can occur among the skeletal complications.

• Hip fractureRelated: Fragile bone makes low-energy falls a frequent cause of hip fracture in older adults.

• Human nutritionRelated: Calcium, vitamin D, and other factors in nutrition affect bone health.

• Rib cageRelated: Weakened ribs can fracture under forces that a healthy cage would withstand.

• Calcium citrateRelated: Calcium intake supports bone health but does not alone prevent or treat osteoporosis.

• Epidermolysis bullosaRelated: Chronic inflammation, limited mobility, and nutritional problems can weaken bone in severe EB.

• Human skeletonRelated: It shows how loss of skeletal mass and structure can compromise protection and mobility.

• MethylprednisoloneRelated: Long-term systemic glucocorticoid exposure can accelerate bone loss.

• Skeleton (anatomy)Related: It shows how changes in skeletal tissue can weaken the framework.

• NandroloneRelated: Nandrolone has had limited medical use in conditions involving bone loss.

• Werner syndromeRelated: It is among the age-associated conditions that can develop prematurely in Werner syndrome.

• Bone (anatomy)Related: It shows how changes in bone mass and architecture weaken the skeleton.

• Endocrine system diseasesRelated: Excess parathyroid hormone or cortisol can weaken bone over time.

• Human musculoskeletal systemRelated: It shows how changes in bone structure can compromise mechanical support.

• Sex differences in humansRelated: Average bone mass and age-related hormonal changes contribute to sex differences in risk.